SMMT
Summit Therapeutics Inc
Price:  
24.55 
USD
Volume:  
12,732,495.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SMMT Intrinsic Value

-104.88 %
Upside

What is the intrinsic value of SMMT?

As of 2025-07-07, the Intrinsic Value of Summit Therapeutics Inc (SMMT) is -1.20 USD. This SMMT valuation is based on the model Peter Lynch Fair Value. With the current market price of 24.55 USD, the upside of Summit Therapeutics Inc is -104.88%.

Is SMMT undervalued or overvalued?

Based on its market price of 24.55 USD and our intrinsic valuation, Summit Therapeutics Inc (SMMT) is overvalued by 104.88%.

Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.

24.55 USD
Stock Price
-1.20 USD
Intrinsic Value
Intrinsic Value Details

SMMT Intrinsic Value - Valuation Summary

Range Selected Upside
a
Fair Value -1.20 - -1.20 -1.20 -104.88%
P/E (2.46) - (4.47) (3.21) -113.1%
DDM - Stable (1.56) - (4.63) (3.10) -112.6%
DDM - Multi (0.10) - (0.23) (0.14) -100.6%

SMMT Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 18,232.55
Beta 3.25
Outstanding shares (mil) 742.67
Enterprise Value (mil) 18,021.02
Market risk premium 4.60%
Cost of Equity 11.69%
Cost of Debt 5.00%
WACC 7.68%